Welcome to our Research Group

iPSCs and CRISPR-Cas9 Technologies for Rare Disease Modeling, Drug Discovery, and Precision Medicine

  • Our research utilizes human-induced pluripotent stem cells (iPSCs) to investigate rare diseases, drive drug discovery, and conduct toxicity studies using iPSC-derived cellular models. 
  • ​We integrate CRISPR-Cas9 genome editing to uncover disease mechanisms and develop targeted therapies. 
  • A key focus of our work is identifying novel biomarkers and therapeutic targets to advance precision medicine.​​
    ​